Actively Recruiting
Neurobiological Mechanisms of Aging and Stress on Prospective Navigation
Led by Georgia Institute of Technology · Updated on 2026-04-17
85
Participants Needed
1
Research Sites
362 weeks
Total Duration
On this page
Sponsors
G
Georgia Institute of Technology
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Two hallmarks of both healthy aging and age-related disease are 1) memory and navigational deficits, particularly in orienting towards goal locations and planning how to navigate to them, and 2) increased susceptibility to stress and altered regulation of the stress response. However, there are marked individual differences in these age-related changes. The investigators' proposal will help characterize factors that contribute to this variability. Participants will be pseudorandomly assigned to stress-manipulated or control groups. The investigators will give both groups a novel immersive navigation task, validated by the PI in healthy young adults. This paradigm gives participants the opportunity to either (a) flexibly draw on spatial memory in order to plan efficient routes to goal locations, or (b) fall back on inefficient, but cognitively less-demanding, stimulus-response associations (i.e., habits). Using neuroimaging and behavioral measures, the investigators' protocol will test whether experimentally-induced stress leads individuals to bring fewer details about future locations to mind when route planning, and whether such restricted prospective thought ultimately biases participants towards relatively inflexible, habitual actions.
CONDITIONS
Official Title
Neurobiological Mechanisms of Aging and Stress on Prospective Navigation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 65 to 80 years
- U.S. citizens or permanent residents
- Fluent in English
- Willing to attend group testing sessions at Georgia Tech
You will not qualify if you...
- Contraindications to MRI or electrical shock stimulation (e.g., metal implants, heart arrhythmia, cardiovascular medications such as beta-blockers)
- Diagnosis of epilepsy, dementia, Parkinson's disease, history of stroke or seizure
- Psychiatric disorders or untreated depression
- Attention Deficit Disorder or Multiple Sclerosis
- Uncontrolled high or low blood pressure
- Untreated diabetes
- Sickle Cell Anemia
- Regular use of illegal or psychoactive drugs, including alcohol abuse
- Scoring below 3 on WAIS-R forward span, below 2 on WAIS-R backward span, or inability to name more than 2 vegetables (indicating possible cognitive impairment or dementia)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Center for Advance Brain Imaging
Atlanta, Georgia, United States, 30318
Actively Recruiting
Research Team
T
Thackery I Brown, Ph.D.
CONTACT
S
Scott Moffat, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here